Search results
- 1.0473062 - ÚMG 2017 RIV US eng J - Journal Article
Šímová, Jana - Sapega, Olena - Imrichová, Terezie - Štěpánek, Ivan - Kyjacová, Lenka - Mikyšková, Romana - Indrová, Marie - Bieblová, Jana - Bubeník, Jan - Bártek, Jiří - Hodný, Zdeněk - Reiniš, Milan
Tumor growth accelerated by chemotherapy-induced senescent cells is suppressed by treatment with IL-12 producing cellular vaccines.
OncoTarget. Roč. 7, č. 34 (2016), s. 54952-54964. ISSN 1949-2553
R&D Projects: GA MZd NT14461
Institutional support: RVO:68378050
Keywords : cellular senescence * cancer chemotherapy * docetaxel * IL-12 * cell therapy
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 5.168, year: 2016
Permanent Link: http://hdl.handle.net/11104/0270230 - 2.0395907 - ÚMG 2014 RIV DE eng J - Journal Article
Rosalia, Rodney Alexander - Štěpánek, Ivan - Polláková, Veronika - Šímová, Jana - Bieblová, Jana - Indrová, Marie - Moravcová, Simona - Přibylová, Hana - Bontkes, H. - Bubeník, Jan - Sparwasser, T. - Reiniš, Milan
Administration of anti-CD25 mAb leads to impaired alpha-galactosylceramide-mediated induction of IFN-gamma production in a murine model.
Immunobiology. Roč. 218, č. 6 (2013), s. 851-859. ISSN 0171-2985
R&D Projects: GA ČR GA301/07/1410; GA ČR GAP301/10/2174
Institutional research plan: CEZ:AV0Z50520514
Institutional support: RVO:68378050
Keywords : cancer immunotherapy * DEREG mice * interferon γ * natural killer T cells * PC61 monoclonal antibody * T regulatory cells
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 3.180, year: 2013
Permanent Link: http://hdl.handle.net/11104/0228410File Download Size Commentary Version Access 0395907.pdf 7 922.6 KB Publisher’s postprint require - 3.0371270 - ÚMG 2012 RIV IT eng J - Journal Article
Štěpánek, Ivan - Indrová, Marie - Bieblová, Jana - Fučíková, J. - Spíšek, R. - Bubeník, Jan - Reiniš, Milan
Effects of 5-azacytidine and trichostatin a on dendritic cell maturation.
Journal of Biological Regulators and Homeostatic Agents. Roč. 25, č. 30 (2011), s. 519-531. ISSN 0393-974X. E-ISSN 1724-6083
R&D Projects: GA ČR GAP301/10/2174; GA ČR GA301/09/1024; GA AV ČR IAA500520605
Grant - others:EU-FP6(XE) LSHB-CT-2006-018933
Institutional research plan: CEZ:AV0Z50520514
Keywords : 5-azacytidine * MHC class I downregulation * tumour chemoimmunotherapy
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 5.183, year: 2011
Permanent Link: http://hdl.handle.net/11104/0204822 - 4.0371265 - ÚMG 2012 RIV GB eng J - Journal Article
Šímová, Jana - Polláková, Veronika - Indrová, Marie - Mikyšková, Romana - Bieblová, Jana - Štěpánek, Ivan - Bubeník, Jan - Reiniš, Milan
Immunotherapy augments the effect of 5-azacytidine on HPV16-associated tumours with different MHC class I-expression status.
British Journal of Cancer. Roč. 105, č. 10 (2011), s. 1533-1541. ISSN 0007-0920. E-ISSN 1532-1827
R&D Projects: GA ČR GA301/07/1410; GA ČR GAP301/10/2174; GA ČR GA301/09/1024
EU Projects: European Commission(XE) 18933 - CLINIGENE
Institutional research plan: CEZ:AV0Z50520514
Keywords : 5-azacytidine * MHC class I downregulation * tumour chemoimmunotherapy
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 5.042, year: 2011
Permanent Link: http://hdl.handle.net/11104/0204817File Download Size Commentary Version Access 0371265.pdf 5 5.6 MB Publisher’s postprint require - 5.0365072 - ÚMG 2012 RIV GR eng J - Journal Article
Mikyšková, Romana - Indrová, Marie - Šímová, Jana - Bieblová, Jana - Bubeník, Jan - Reiniš, Milan
Genetically modified tumour vaccines producing IL-12 augment chemotherapy of HPV16-associated tumours with gemcitabine.
Oncology Reports. Roč. 25, č. 6 (2011), s. 1683-1689. ISSN 1021-335X. E-ISSN 1791-2431
R&D Projects: GA ČR GA301/09/1024; GA ČR GA301/07/1410
Grant - others:EK(XE) EU-FP6-NOE018933
Institutional research plan: CEZ:AV0Z50520514
Keywords : gemcitabine * human papilloma virus * interleukin 12 * lung metastases * cellular vaccines * immunotherapy
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 1.835, year: 2011
Permanent Link: http://hdl.handle.net/11104/0200408File Download Size Commentary Version Access 0365072.pdf 10 440.2 KB Publisher’s postprint require - 6.0360540 - ÚMG 2012 CZ eng J - Journal Article
Bubeník, Jan
Interleukin 12 in cancer treatment.
Folia Biologica. Roč. 57, č. 1 (2011), s. 1-2. ISSN 0015-5500. E-ISSN 0015-5500
Institutional research plan: CEZ:AV0Z50520514
Keywords : interleukin 12 * cancer therapy
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 1.151, year: 2011
Permanent Link: http://hdl.handle.net/11104/0198057 - 7.0355110 - ÚMG 2011 RIV GR eng J - Journal Article
Indrová, Marie - Šímová, Jana - Bieblová, Jana - Bubeník, Jan - Reiniš, Milan
NK1.1+ cells are important for the development of protective immunity against MHC I-deficient, HPV16-associated tumours.
Oncology Reports. Roč. 25, č. 1 (2011), s. 281-288. ISSN 1021-335X. E-ISSN 1791-2431
R&D Projects: GA AV ČR IAA500520807
Grant - others:EU-FP6-NOE(XE) Project 018933
Institutional research plan: CEZ:AV0Z50520514
Keywords : MHC class I-deficient tumours * CD8+, CD4+, NK1.1+cell subpopulations * interferon gamma
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 1.835, year: 2011
Permanent Link: http://hdl.handle.net/11104/0193953 - 8.0355108 - ÚMG 2011 CZ eng J - Journal Article
Bubeník, Jan
Genetically modified vaccines augment the efficacy of cancer surgery and chemotherapy.
Folia Biologica. Roč. 55, č. 6 (2009), s. 199-200. ISSN 0015-5500. E-ISSN 0015-5500
Institutional research plan: CEZ:AV0Z50520514
Keywords : genetically modified vaccines * cancer surgery and chemotherapy
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 0.924, year: 2009
Permanent Link: http://hdl.handle.net/11104/0193951 - 9.0346751 - ÚMG 2011 RIV GR eng J - Journal Article
Bubeník, Jan - Šímová, Jana
Genetically modified cellular vaccines against human papillomavirus type 16 (HPV16)-associated tumors: adjuvant treatment of minimal residual disease after surgery/chemotherapy.
Journal of Balkan Union of Oncology. Roč. 14, č. 1 (2009), s. 169-173. ISSN 1107-0625. E-ISSN 2241-6293
R&D Projects: GA ČR GA301/06/0774; GA ČR GA301/07/1410
EU Projects: European Commission(XE) 18933 - CLINIGENE
Institutional research plan: CEZ:AV0Z50520514
Keywords : residual tumour disease * HPV16 * cellular vaccines
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 0.600, year: 2009
Permanent Link: http://hdl.handle.net/11104/0187687 - 10.0346747 - ÚMG 2011 RIV GR eng J - Journal Article
Reiniš, Milan - Štěpánek, Ivan - Šímová, Jana - Bieblová, Jana - Přibylová, Hana - Indrová, Marie - Bubeník, Jan
Induction of protective immunity against MHC class I-deficient, HPV16-associated tumours with peptide and dendritic cell-based vaccines.
International Journal of Oncology. Roč. 36, č. 3 (2010), s. 545-551. ISSN 1019-6439. E-ISSN 1791-2423
R&D Projects: GA AV ČR IAA500520605; GA AV ČR IAA500520807
EU Projects: European Commission(XE) 18933 - CLINIGENE
Institutional research plan: CEZ:AV0Z50520514
Keywords : MHC class I-deficient tumours * CpG oligodeoxynucleotides * human papilloma virus
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 2.571, year: 2010
Permanent Link: http://hdl.handle.net/11104/0187685File Download Size Commentary Version Access 0346747.pdf 3 515.8 KB Publisher’s postprint require